Literature DB >> 6902981

Kinetics of the different susceptibilities of the four human immunoglobulin G subclasses to proteolysis by human lysosomal elastase.

A Baici, M Knöpfel, K Fehr, F Skvaril, A Böni.   

Abstract

Human lysosomal elastase cleaves human monoclonal IgG into components that closely resemble the fragments produced by papain digestion. IgG1 produced Fab, Fc and Fab-Fc fragments; cleavage of IgG2 produced F(ab)2, Fab-Fc, Fab and Fc fragments; IgG3 gave rise to almost pure Fab and Fch (Fc covalently joined to the extended hinge region polypeptide of IgG3), and from IgG4, F(ab)2, Fab and Fc fragments were recovered. The relative susceptibilities of the four human IgG subclasses to proteolytic attack by elastase were studied kinetically and showed the following decreasing order of susceptibility: IgG3 > IgG1 > IgG2 > IgG4. The Fab fragment from papain digestion of IgG1 and the corresponding fragment from elastase digestion showed indistinguishable molecular weights and immunochemical identity.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6902981     DOI: 10.1111/j.1365-3083.1980.tb00039.x

Source DB:  PubMed          Journal:  Scand J Immunol        ISSN: 0300-9475            Impact factor:   3.487


  6 in total

1.  The in vitro resistance of IgG2 to proteolytic attack concurs with a comparative paucity of autoantibodies against peptide analogs of the IgG2 hinge.

Authors:  Randall J Brezski; Allison Oberholtzer; Brandy Strake; Robert E Jordan
Journal:  MAbs       Date:  2011-11-01       Impact factor: 5.857

2.  The recirculating lymphocyte pool of the rat: a systematic description of the migratory behaviour of recirculating lymphocytes.

Authors:  M E Smith; W L Ford
Journal:  Immunology       Date:  1983-05       Impact factor: 7.397

3.  Protein synthesis in rheumatoid synovial tissue.

Authors:  J D Smiley; W L Hoffman
Journal:  Springer Semin Immunopathol       Date:  1981

4.  Hinge-Region O-Glycosylation of Human Immunoglobulin G3 (IgG3).

Authors:  Rosina Plomp; Gillian Dekkers; Yoann Rombouts; Remco Visser; Carolien A M Koeleman; Guinevere S M Kammeijer; Bas C Jansen; Theo Rispens; Paul J Hensbergen; Gestur Vidarsson; Manfred Wuhrer
Journal:  Mol Cell Proteomics       Date:  2015-03-10       Impact factor: 5.911

5.  Coming together at the hinges: Therapeutic prospects of IgG3.

Authors:  Thach H Chu; Edward F Patz; Margaret E Ackerman
Journal:  MAbs       Date:  2021 Jan-Dec       Impact factor: 5.857

Review 6.  How immune complexes from certain IgG NAbs and any F(ab')₂ can mediate excessive complement activation.

Authors:  Hans U Lutz
Journal:  Adv Exp Med Biol       Date:  2012       Impact factor: 2.622

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.